Tlwm Makes New Investment in Globe Life Inc. $GL

Tlwm bought a new stake in shares of Globe Life Inc. (NYSE:GL) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 4,700 shares of the company’s stock, valued at approximately $840,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in GL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Globe Life by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company’s stock valued at $1,237,000 after buying an additional 607 shares during the period. NewEdge Advisors LLC increased its position in Globe Life by 368.1% during the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company’s stock valued at $897,000 after purchasing an additional 5,352 shares during the period. Goldman Sachs Group Inc. raised its stake in Globe Life by 11.5% in the first quarter. Goldman Sachs Group Inc. now owns 563,021 shares of the company’s stock worth $74,161,000 after buying an additional 58,163 shares in the last quarter. Empowered Funds LLC purchased a new stake in shares of Globe Life during the 1st quarter worth $428,000. Finally, Focus Partners Wealth lifted its position in shares of Globe Life by 8.3% during the first quarter. Focus Partners Wealth now owns 8,559 shares of the company’s stock valued at $1,127,000 after buying an additional 656 shares during the last quarter. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Trading Down 0.1%

Shares of NYSE GL opened at $183.81 on Thursday. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38. The stock has a market capitalization of $14.27 billion, a PE ratio of 12.20 and a beta of 0.48. The stock has a fifty day simple moving average of $173.21 and a 200-day simple moving average of $155.25. Globe Life Inc. has a twelve month low of $127.85 and a twelve month high of $191.55.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, July 22nd. The company reported $3.61 EPS for the quarter, missing analysts’ consensus estimates of $3.67 by ($0.06). Globe Life had a net margin of 19.58% and a return on equity of 20.73%. The business had revenue of $1.60 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same quarter in the previous year, the company posted $3.05 EPS. The company’s revenue was up 8.0% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 15.550-15.950 EPS. On average, equities analysts forecast that Globe Life Inc. will post 15.7 earnings per share for the current year.

Insider Activity

In other news, EVP Michael Clay Majors sold 37,000 shares of the firm’s stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the completion of the sale, the executive vice president owned 53,518 shares in the company, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Cheryl Alston sold 8,258 shares of the firm’s stock in a transaction dated Thursday, June 25th. The shares were sold at an average price of $179.24, for a total transaction of $1,480,163.92. Following the completion of the sale, the director owned 16,621 shares of the company’s stock, valued at approximately $2,979,148.04. The trade was a 33.19% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 219,174 shares of company stock worth $37,675,349 over the last quarter. 2.11% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several brokerages recently commented on GL. TD Cowen increased their price objective on shares of Globe Life from $215.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Piper Sandler boosted their price objective on Globe Life from $175.00 to $200.00 and gave the company an “overweight” rating in a report on Wednesday, July 15th. JPMorgan Chase & Co. boosted their target price on shares of Globe Life from $181.00 to $201.00 and gave the company an “overweight” rating in a research note on Tuesday, July 21st. Keefe, Bruyette & Woods reduced their price target on Globe Life from $192.00 to $190.00 and set an “outperform” rating for the company in a report on Friday, July 24th. Finally, Morgan Stanley increased their price objective on shares of Globe Life from $181.00 to $208.00 and gave the company an “overweight” rating in a report on Monday, July 6th. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, Globe Life has a consensus rating of “Moderate Buy” and a consensus target price of $191.67.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.